2022
DOI: 10.1227/neu.0000000000002274
|View full text |Cite
|
Sign up to set email alerts
|

Deep Brain Stimulation for Advanced Parkinson Disease in Developing Countries: A Cost-Effectiveness Study From China

Abstract: BACKGROUND:The cost-effectiveness of deep brain stimulation (DBS) is more favorable than best medical treatment (BMT) for advanced Parkinson disease (PD) in developed countries. However, it remains unclear in developing countries, where the cost of DBS may not be reimbursed by health care system.OBJECTIVE:To model and evaluate the long-term cost-effectiveness of DBS for advanced PD in China from a patient payer perspective.METHODS:We developed a Markov model representing the clinical progress of PD to predict … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 35 publications
(40 reference statements)
0
1
0
Order By: Relevance
“…It is important to note that the studies included in our report did not compare the cost of DBS to the reimbursement received; therefore, an assessment of the true profitability of DBS is difficult to ascertain. However, DBS was deemed cost-effective in comparison to best medical therapies, supporting its value from a patient-centered cost analysis perspective [53,54].…”
Section: Bundling Procedures and Cost Reportingmentioning
confidence: 99%
“…It is important to note that the studies included in our report did not compare the cost of DBS to the reimbursement received; therefore, an assessment of the true profitability of DBS is difficult to ascertain. However, DBS was deemed cost-effective in comparison to best medical therapies, supporting its value from a patient-centered cost analysis perspective [53,54].…”
Section: Bundling Procedures and Cost Reportingmentioning
confidence: 99%